Person: Leerink

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Vaccine drug developer AstraZeneca 'seeks merger with Covid-19 treatment firm Gilead'

AstraZeneca has approached rival drugmaker Gilead Sciences about a potential merger, according to sources, in what would be the biggest health-care deal on record.

Sun, 07 Jun, 2020

Pfizer’s €12bn deal hints at change

Pfizer has clinched the purchase of US cancer drug company Medivation in a deal valued at about $14bn, (€12.4bn) adding blockbuster prostate cancer drug Xtandi to its portfolio.

Tue, 23 Aug, 2016

Person: Leerink

Vaccine drug developer AstraZeneca 'seeks merger with Covid-19 treatment firm Gilead'

Pfizer’s €12bn deal hints at change

Latest

Mick Clifford

Person: Leerink

Vaccine drug developer AstraZeneca 'seeks merger with Covid-19 treatment firm Gilead'

Pfizer’s €12bn deal hints at change

Latest

Mick Clifford

Most Read